semaglutide tablet Wegovy® - for oral use Ozempic Pill Approved by FDA:

JAK inhibitors (tofacitinib, upadacitinib) and S1P modulators (ozanimod) represent additional treatment options for moderate-to-severe disease

Journals Gerontology Ser

Politi et al., 2008

The STEP trial programme (which primarily enrolled adults without type 2 diabetes) showed that participants with obesity achieved an average weight loss of approximately 15% of their initial body weight over 68 weeks, compared to 2.4% with placeboall participants also received lifestyle intervention

By potentially creating new vascular pathways to the site of the annulus tear, BPC-157 could theoretically deliver the raw materials needed for repair